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Background The association between increased body mass index (BMI) and subsequent mortality remains unclear in Asians. This study investigated the associations between BMI increases and cause-specific mortality in middle-aged Korean men.
Methods
We conducted a retrospective cohort study of 473 358 Korean men aged 30-64 years, who had undergone health examinations in both 1992 and 1998 and were followed up during 1998-2004. Cox proportional hazards for cause-specific 7-year mortality in relation to BMI changes after stratification of baseline BMI status were analysed.
Results
Mortality from cardiovascular disease (CVD) was associated with BMI in both 1992 and 1998. Non-CVD mortality was inversely associated with BMI in both 1992 and 1998. We cross-classified participants into groups based on their baseline BMI levels and percent BMI changes during follow-up; men with the lowest BMI level at baseline (BMI in 1992 <21 kg/m 2 ) and stable BMI during follow-up (percent change in BMI <5%) were included in the reference category. Compared with the reference group, CVD mortality was higher in initially obese men (BMI in 1992 525 kg/m 2 ) with any increase of BMI, and in initially lean men (BMI in 1992 <21 kg/m 2 ) or initially overweight men (BMI in 1992 23-24.9 kg/m 2 ) with BMI increases of 510%. BMI increases of 5.0-9.9% in men with baseline BMI <25 kg/m 2 and stable BMI in men with baseline BMI 521 kg/m 2 appeared to lower the risk for non-CVD or all-cause mortality, to below the levels seen in the reference group.
Conclusions Among middle-aged Korean men, obesity or severe weight gain was detrimental to CVD mortality. An increase in BMI appeared to have a predictive value for CVD mortality, especially when used in combination with baseline BMI level. In contrast, moderate weight gain in non-obese men seemed to protect against non-CVD and all-cause mortality.
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Introduction
Severe obesity increases the risks of morbidity and mortality from cardiovascular disease (CVD). [1] [2] [3] Several studies have shown that the prevalence of risk factors for CVD increases in a dose-dependent manner with increasing body mass index (BMI) in comparatively lean adults. [4] [5] [6] However, obesity may be a weaker adverse factor for non-CVD or all-cause mortality. Several studies have reported U-shaped or J-shaped relationships between mortality and BMI, [7] [8] [9] [10] with variation according to pre-existing disease and smoking status.
In the Asia-Pacific region, rapid increases in the number of overweight and obese people have been accompanied by dramatic increases in the rate of CVD. 11, 12 Although the prevalence of BMI 530 kg/m 2 in Asian populations is low, CVD occurs at lower BMI levels in Asians than in Caucasians. [13] [14] [15] A large study involving eight countries in the Asia-Pacific region identified increasing BMI as a major contributor to the growing incidence of CVD in this area. 16 Previous studies have reported inconsistent results regarding the relationship between BMI changes and subsequent mortality. [17] [18] [19] [20] [21] In some studies, adult weight gain was associated with increased risks for CVD [22] [23] [24] and certain types of cancer, 25 whereas other studies reported that weight loss (rather than weight gain) was associated with higher CVD, non-CVD and total mortality. 17, 26 Similarly, there are some questions regarding the strength of the association between BMI changes and mortality. A recent study suggested that the association between mortality and BMI at a given age depends on BMI at earlier ages. 19 However, such associations have not yet been well established in an Asian population. Here, we investigate the relationship between cause-specific mortality and increases in BMI over a 7-year period in a large cohort of middle-aged Korean men with stratification by initial BMI status.
Methods

Study subjects
The data studied were obtained from Medical Insurance Corporation records for middle-aged Korean men who had undergone health examinations in both 1992 and 1998. The Korean Medical Insurance Corporation provides health insurance to government employees, teachers and their dependents in the Republic of Korea. In 1992, the corporation insured 1 297 833 workers and 3 364 605 dependents, $10.7% of the total Korean population. The corporation required all insured workers to take a biennial health examination. The examinations were conducted in a standardized manner by trained medical staff at community hospitals nationwide. In 1992, 94% of the insured workers completed examinations.
Out of 718 694 men aged 19-71 years who attended both the 1992 and 1998 examinations, we initially selected 570 894 apparently healthy Korean men aged 30-64 years as our study subjects. We excluded seniors aged 565 years and younger men aged <30 years who were in the transition from adolescence to adulthood. From our pool of middle-aged men, we excluded individuals with a history of cancer (43 484 individuals) or atherosclerotic disease [ischaemic heart disease (HD) or stroke; 10 370 individuals] prior to the 1998 examination, in order to rule out the possibility of these diseases influencing our outcome measurement (i.e. mortality after 1998). In addition, subjects whose BMI decreased by 45% between 1992 and 1998 (43 537 individuals) were excluded to avoid the confounding effects of hidden debilitating disease or intentional weight loss during the follow-up period. After the exclusion of subjects for which there were incomplete data (145 individuals), the final study population consisted of 473 358 individuals.
Basic questionnaire and definition of BMI increase At the time of the health examination, each patient was asked to fill out a questionnaire regarding his family history, past medical history, smoking habits, alcohol consumption and exercise habits. Family history was assessed according to the presence or absence of hypertension (HT), diabetes mellitus (DM), HDs or stroke in first-degree relatives. Past medical history was also assessed according to the presence or absence of the above-mentioned diseases. Individuals were categorized as non-smokers, exsmokers or current smokers. The frequencies of alcohol consumption and exercise were reported as either none, 1-2 days a week or 43 days a week.
All of the medical institutes that conducted such health examinations were equipped with standardized measuring devices authorized by the Korean Association of Quality Control. Anthropometric measurements were performed by registered nursing staff members. Body weight (kg) and height (cm) were measured to the first decimal place in light clothing with no shoes on. BMI was calculated as weight (kg) divided by the square of the height (m). In this study, overweight and obesity were defined as BMI values of 23-24.9 kg/m 2 and 525 kg/m 2 , respectively. 8 Participants were categorized in terms of BMI changes between 1992 and 1998; the percent changes in BMI were categorized as follows: <5% change (stable), an increase of 5.0-9.9% (moderate increase) and an increase of 510.0% (severe increase).
Determination of cause-specific mortality
The follow-up period was up to 7 years, through 31 December 2004; the follow-up time was the interval between the date of the examination in 1998 and the date of the event. Our mortality follow-up study was based on computerized searches of death certificate data from the Korean National Statistical Office; these data were verifiably linked to the subjects in this study based on a unified 13-digit identification number. In Korea, professionally trained and certified medical chart recorders summarize, chart and complete death certificates using information provided by physicians. All death certificates are registered with the Korean National Statistical Office, even when individuals die outside Korea. Therefore, the utilized mortality follow-up data are likely to be almost 100% complete. The principal outcome variables examined were CVD mortality, non-CVD mortality and all-cause mortality. Deaths from CVD included those due to hypertensive disease (ICD-10 codes I10-I15), ischaemic HD (ICD-10 codes I20-I25), cerebrovascular disease (ICD-10 codes I60-I69) and other forms of HD, including sudden death (ICD-10 codes I30-I52), atherosclerosis (ICD-10 code I70) and other unspecified disorders of the circulatory system (ICD-10 codes I95-I99).
Statistical analysis
The baseline characteristics of the study population according to BMI change were compared using oneway ANOVA and chi-square tests. The relationship between cause-specific mortality and BMI in 1992 or 1998 was analysed using the Cox proportional hazards regression model. Cause-specific mortality in relation to BMI change was analysed with adjustments for age, family history, past medical history, smoking habits, alcohol consumption, exercise habits and BMI in 1992, not to take away between-subject variability in BMI at baseline and follow-up. 27 We analysed the association between BMI increases and cause-specific mortality after stratification according to the BMI quartiles in 1992 (BMI <20.9, 21-22.9, 23-24.9 and 525 kg/m 2 ). Relative risks (RRs) for cause-specific mortality are presented with their 95% confidence intervals (CIs). In addition, participants were cross-classified into groups based on baseline BMI level and percent BMI change at follow-up. We calculated the P-values for the interaction between BMI at baseline and BMI change for effect modification. Statistical analyses were conducted using SAS Version 9.1 software.
Results
Basic characteristics by BMI change in the study population Basic characteristics stratified by BMI change from 1992 to 1998 are shown in Cause-specific mortality according to BMI in 1992, in 1998 and BMI increases from 1992 to 1998 We examined cause-specific mortalities according to BMI in 1992, in 1998 and BMI change from 1992 to 1998 (Table 2 ). During the follow-up period between 1998 and 2004 (i.e. 3 079 635 person-years), 1321, 6289 and 7610 of the study subjects died from CVD, non-CVD and all-causes, respectively. CVD mortality was associated with BMI in both 1992 and 1998, whereas non-CVD mortality was inversely associated with BMI in both 1992 and 1998. All-cause mortality lacked a clear pattern, although men with BMI <21 kg/m 2 had the highest risk for total mortality. Regarding changes in BMI from 1992 to 1998, men with severe BMI increases (percent increase in BMI 510%) had higher risks for CVD, non-CVD and all-cause mortality.
Cause-specific mortality according to BMI changes between 1992 and 1998 after stratification by BMI status in 1992 Table 3 shows cause-specific mortality according to BMI changes between 1992 and 1998 after stratification by BMI status in 1992. In the table, the stable BMI category (percent change in BMI <5%) within that stratum was the reference group for each BMI stratum in 1992. In participants with baseline BMI <21 kg/m 2 , men with severe BMI increase (percent increase in BMI 510%) had a higher RR for CVD mortality compared with those who had a stable BMI during follow-up (percent change in BMI <5%) in that stratum. In participants with baseline BMI 523 kg/m 2 , men with severe BMI increase (percent increase in BMI 510%) had a higher RR for non-CVD mortality and overall mortality compared with the reference group.
Cause-specific mortality after crossclassification in relation to BMI status in 1992 and BMI changes from 1992 to 1998 We cross-classified participants into groups based on their baseline BMI level and percent BMI change during follow-up, using men with the lowest BMI level at baseline (BMI in 1992 <21 kg/m 2 ) and stable BMI during follow-up (percent change in BMI <5%) as the reference category in the entire group (Table 4) . Compared with the reference group, initially obese men (BMI in 1992 525 kg/m 2 ) had a higher RR for CVD mortality regardless of the degree of BMI increase during follow-up. Additionally, higher RRs for CVD mortality were seen in the following: initially overweight men (BMI in 1992; 23-24.9 kg/m 2 ) with severe BMI increase (percent increase in BMI 510%); and men with the lowest BMI level at baseline (BMI in 1992 <21 kg/m 2 ) but a severe BMI increase at follow-up (percent increase in BMI 510%). The interaction between BMI at baseline and BMI change for CVD mortality was not statistically significant. However, the increased risk for non-CVD and all-cause mortality disappeared for men with severe BMI increases (percent increase in BMI 510%) in all categories of BMI in 1992. Notably, men with baseline BMI 521 kg/m 2 and stable BMI during follow-up (percent change in BMI <5%), and men with baseline BMI <25 kg/m 2 and moderate BMI increases (percent increase in BMI; 5.0-9.9%) showed significantly lower RR for non-CVD mortality and overall mortality compared with the reference group. There were statistically significant interactions between BMI at baseline and BMI change for non-CVD mortality as well as overall mortality.
Discussion
Our retrospective cohort study of middle-aged Korean men revealed that the associations between BMI and mortality differ by cause of death in this population. CVD mortality increased and non-CVD mortality decreased with BMI at baseline and follow-up. Overall mortality lacked a clear pattern, although men with BMI <21 kg/m 2 had the highest risk for total mortality. In addition, the association of severe BMI increases (percent increase in BMI 510%) among initially lean men (BMI in 1992 <21 kg/m 2 ) with an increased risk of CVD mortality was stronger than that among initially obese men, and the associations of severe BMI increases among men with baseline BMI 523 kg/m 2 with an increased risk of 
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non-CVD and all-cause mortality were stronger than those among initially lean men. In cross-classified participants based on baseline BMI level and percent BMI change at follow-up, initially lean men (BMI <21 kg/m 2 ) whose BMI increased severely (percent increase in BMI 510%) over the follow-up period showed significant mortality from CVD, to a degree similar to that experienced by initially obese men (BMI 525 kg/m 2 ) with any change of BMI. However, moderate BMI increases in men with baseline BMI <25 kg/m 2 and stable BMI in men with baseline BMI 521 kg/m 2 were associated with lower risks of non-CVD or all-cause mortality.
Previous studies in Western countries found that weight gain (i.e. 510 kg or 510%) was significantly associated with increased mortality from coronary HD. 18, 21 A recent Japanese study found that men with an initial BMI <21.7 kg/m 2 who gained 410 kg had a 2-fold higher risk of coronary HD compared with men having similar initial BMI whose weight did not change. 22 Consistent with these previous reports, we found that BMI increases 510% in middle-aged Korean men who were initially lean, even if those men stayed within the normal BMI range, raised the risk of CVD mortality. We further found that increased BMI was predictive of CVD mortality, especially when used in combination with the baseline BMI level.
Our finding that excessive weight gain in middleaged men conferred an increased risk for CVD mortality may yield interesting insights into determining the life periods during which changes in body weight (or BMI) may be important in determining the subsequent risk of CVD death. A previous study suggested that high BMI in early adulthood was positively related to CVD mortality in later life in men, and the risk associated with adiposity appeared to be greater in early adulthood than in mid-adulthood. 20 The authors proposed the existence of a critical period during which overweight confers an increased risk of disease later in life. 20 The total adipocyte number increases in childhood and adolescence, then levels off and remains constant during adulthood in both lean and obese individuals. 28 A significant weight gain in adult men results in a significant increase in body fat, which is accompanied by an increase in adipocyte volume, but no change in adipocyte number. 28 Although it is unknown whether there is a critical age at which high BMI is particularly harmful for CVD mortality, our present findings suggest that excessive weight gain even in middle age can contribute to a higher risk for CVD mortality. We found that initially lean men who experienced severe increases in BMI over the 7-year study period showed greatly increased mortality from CVD. Not only the amount but also the rate of fat accumulation may be associated with higher risks of obesity related diseases. 29 According to the thrifty phenotype hypothesis, the adaptative capacity of energy metabolism is formed during the fetal period; 30 however, such characteristics may still be present during both childhood and adulthood, depending on the timing of exposure to the obesogenic environment. Since the crucial trigger for increased risk for weight gain in later life is the discrepancy between an organism's metabolic capacity and its environmental load, the rate of exposure to metabolic demand is likely to matter. Obesity-related diseases arise from fat accumulation Table 4 RRs (95% CI) of death from CVD, non-CVD and all-cause after cross-classification in relation to BMI changes from 1992 to 1998 and BMI status in 1992 within the body; a higher fat accumulation rate may limit an individual's ability to deal with the toxicity of the growing adipose mass. During adulthood, progressive increases in body fat and decreases in fat-free mass have been noted. 31 Moreover, ageing causes a loss of subcutaneous fat, accumulation of visceral fat and ectopic fat deposition. 32 Although body fat distribution data were not assessed in our study, the BMI increases observed in the middle-aged Korean men studied herein over the 7-year period were likely to be due to increases in visceral fat with increases in age. 32 Our study demonstrated that non-CVD and all-cause mortality decreased with both baseline and follow-up BMI. A recent collaborative analysis of 57 prospective studies including a total of 900 000 adults showed that BMI both above and below the apparent optimum of $22.5-25 kg/m 2 was associated with a higher risk for overall mortality. 33 Notably, however, our present findings suggest that moderate weight gain (percent increase in BMI; 5.0-9.9%) in baseline non-obese men (BMI <25 kg/m 2 ) conveyed a decreased risk for non-CVD and all-cause mortality. Several previous studies found that weight loss appeared to convey higher rates of total and causespecific mortality. 17, 34, 35 Although underlying disease is the most plausible explanation for those findings, that has not yet been empirically proven. Here, we excluded subjects whose BMI decreased by 55% between 1992 and 1998 to rule out prior diseases that could lead to weight loss and potentially early death. We included apparently healthy men whose BMI changed naturally, rather than pathologically or intentionally, in order to observe the associations between BMI changes and mortality in adult life. A previous study in older individuals showed that a net gain or loss of 510 kg between middle and old age was a strong predictor for all-cause and CVD mortality. 19 The patterns of these associations might differ by age group or follow-up period, and the results could depend on the stratification of BMI change or initial BMI status. Here, we stratified our study population into four categories according to the approximate quartiles of baseline BMI in 1992. The utilized cutoffs are similar to those used in a previous study 22 and are found in the guidelines for Asians.
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Our study has several limitations. First, the relatively short study period and the relatively small number of end-points during the follow-up period may have blurred the relationships between BMI increases and mortality risk. Secondly, our findings may not be generalizable to all adults because we studied only in middle-aged Korean men. The results from previous studies suggest that the relationships between BMI increases and mortality risks differ according to various characteristics of the study subjects; these include sex, age group and ethnic background. Accordingly, it is possible that our finding could be generally applicable to middle-aged men, among whom relative weight gain compared with baseline weight occurs mostly during adult life. Thirdly, our use of existing data may have introduced a number of biases, including selection bias, recall bias and/or classification bias. Since lifestyle data were obtained through a one-time questionnaire, some residual confounding may exist in the results for BMI in follow-up. Fourthly, BMI was the only anthropometric measurement available in this study and may be a poor marker for estimation of body fat mass or central obesity, which are more precise indicators for health risks. We did not have access to waist circumference data or information concerning the fluctuation of body weight at the onset of the study. A recent study showed that waist circumference and waist-to-hip ratio are strongly associated with the risk of circulatory cause of death after adjustment for BMI. 36 In addition, we investigated only mortality, not disease incidence. Mortality is obviously affected by disease incidence and lethality, and changes in BMI may affect not only the incidence, but also the prognosis of chronic diseases.
In conclusion, we demonstrate that the associations between BMI level or BMI increase and mortality differ by cause of death in middle-aged Korean men. Obesity or severe weight gain appears to increase CVD mortality, and BMI increase has a predictive value for CVD mortality, especially when used in combination with the baseline BMI level. In contrast, moderate weight gain in non-obese men appears to protect against non-CVD or all-cause mortality.
Severe BMI increase (percent increase in BMI 510%) during the 7-year study period was associated with a higher risk for CVD, even in initially lean men (baseline BMI <21 kg/m 2 ). BMI increase was predictive of CVD mortality, especially when used in combination with baseline BMI level.
Moderate BMI increases (5.0-9.9%) in non-obese men (baseline BMI <25 kg/m 2 ) were associated with lower risks for non-CVD and overall mortality.
